Intermedeol isolated from the leaves of Ligularia fischeri var. spiciformis induces the differentiation of human acute promyeocytic leukemia HL-60 cells

Planta Medica

Volumn 68, Issue 10, 2002, Pages 881-885

  Jeong, Seoung Hee ^a   Koo, Seung Ja ^a   Choi, Jung Hye ^a   Park, Jae Hoon ^b   Ha, Joohun ^b   Park, Hee Juhn ^c   Lee, Kyung Tae ^a  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Sangji University   (South Korea)

Author keywords

C myc; CD14; CD66b; Compositae; Differentiation; HL 60 cells; Intermedeol; Ligularia fischeri var. spiciformis; P21CIP1

Indexed keywords

CD14 ANTIGEN; CD66B ANTIGEN; INTERMEDEOL; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; GRANULOCYTE; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA; LIGULARIA FISCHERI; MONOCYTE; ONCOGENE C MYC; PLANT LEAF; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION;

ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOWN-REGULATION; FLOW CYTOMETRY; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; NAPHTHALENES; PHAGOCYTOSIS; PHYTOTHERAPY; PLANT LEAVES; PROTO-ONCOGENE PROTEINS C-MYC; SENECIO;

ASTERACEAE; LIGULARIA; LIGULARIA FISCHERI;

EID: 0036775482     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-34932     Document Type: Article

References (20)

1. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997; 278: 1073-7
2. Suh N, Luyengi L, Fong HH, Kinghorn AD, Pezzuto JM. Discovery of natural product chemopreventive agents utilizing HL-60 cell differentiation as a model. Anticancer Res. 1995; 15: 233-9
3. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl. Acad. Sci. U S A. 1978; 75: 2458-62
4. Yam LT, Li CY, Crosby WH. Cytochemical identification of monocytes and granulocytes. Am. J. Clin. Pathol. 1971; 55: 283-90
5. Harris PE, Ralph P, Gabrilove J, Welte K, Karmali R, Moore MA. Distinct differentiation-inducing activities of gamma-interferon and cytokine factors acting on the human promyelocytic leukemia cell line HL-60. Cancer Res. 1985; 45: 3090-5
6. Honma Y, Takenaga K, Kasukabe T, Hozumi M. Induction of differentiation of cultured human promyelocytic leukemia cells by retinoids. Biochem. Biophys. Res. Commun. 1980: 95: 507-12
7. 3 and its fluorinated analogues. Cancer Res. 1984; 44: 5624-8
8. 3: Preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro. Proc. Natl. Acad. Sci. U S A. 1987; 84: 2610-4
9. Choi OJ. Usage and Constituents of Medicinal Plants. Seoul: Iweolseogak, 1991: P 621
10. Park HJ, Kwon SH, Yoo KO, Sohn IC, Lee KT, Lee HK. Sesquiterpenes from the leaves of Ligularia fischeri var. spiciformis. Planta Medica 2000; 66: 783-4
11. Lee KT, Sohn IC, Kim YK, Choi JH, Choi JW, Park HJ, Itoh Y, Miyamoto K. Tectorigenin, an isoflavone of Pueraria thunbergiana BENTH., induces differentiation and apoptosis in human promyelocytic leukemia HL-60 cells. Biol. Pharm. Bull. 2001; 24: 1117-21
12. Fesus L, Szondy Z, Uray I. Probing the molecular program of apoptosis by cancer chemopreventive agents. J. Cell Biochem. Suppl. 1995; 22: 151-61
13. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 1998; 282: 1497-501
14. waf1cip1 and concomitant G1 arrest in UV-irradiated human skin fibroblasts. Cancer Res. 1997; 57: 3390-4
15. Danova M, Giordano M, Mazzini G, Riccardi A. Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia. Leuk. Res. 1990; 14: 417-22
16. Filmus J, Buick RN. Relationship of c-myc expression to differentiation and proliferation of HL-60 cells. Cancer Res. 1985; 45: 822-5
17. Todokoro K, Ikawa Y. Sequential expression of proto-oncogenes during a mouse erythroleukemia cell differentiation. Biochem. Biophys. Res. Commun. 1986; 135: 1112-8
18. Baker SJ, Pawlita M, Leutz A, Hoelzer D. Essential role of c-myc in ara-C-induced differentiation of human erythroleukemia cells. Leukemia. 1994; 8: 1309-17
19. Askew DS, Ashmun RA, Simmons BC, Cleveland JL. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene. 1991; 6: 1915-22
20. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science. 1992; 257: 212-4